Difference between revisions of "Ubiquitin"
m |
|||
| Line 37: | Line 37: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ubq.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ubq.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 09:27, 25 July 2007
| Template:Infobox header| Ubiquitin | |
|---|---|
| Ubiquitin | |
| Substrate peptide name | Ubiquitin |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P62988 |
| Reactive glutamines | - |
| Reactive lysines | K29, K48 |
| Substrate sequence | ENVKAKIQDKE
LIFAGKELRDG |
| Structure | 1UBQ |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:15132984 |
| Notes | |
| Template:Infobox header | | |
